(Q52138111)

22 April 2018

title

Elevated plasma amyloid beta-peptide 1-42 and onset of dementia in adults with Down syndrome. (English)

1 reference

22 April 2018

0 references

8

Mayeux R

1 reference

22 April 2018

Schupf N

1

1 reference

22 April 2018

Patel B

2

1 reference

22 April 2018

Silverman W

3

1 reference

22 April 2018

Zigman WB

4

1 reference

22 April 2018

Zhong N

5

1 reference

22 April 2018

Tycko B

6

1 reference

22 April 2018

Mehta PD

7

1 reference

22 April 2018

language of work or name

English

0 references

publication date

1 April 2001

1 reference

22 April 2018

published in

Neuroscience Letters

1 reference

22 April 2018

volume

301

1 reference

22 April 2018

issue

3

1 reference

22 April 2018

page(s)

199-203

1 reference

22 April 2018

Quantitative analysis of senile plaques in Alzheimer disease: observation of log-normal size distribution and molecular epidemiology of differences associated with apolipoprotein E genotype and trisomy 21 (Down syndrome).

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901657-3

7 January 2021

Abeta1-40 but not Abeta1-42 levels in cortex correlate with apolipoprotein E epsilon4 allele dosage in sporadic Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901657-3

7 January 2021

Amyloid beta protein (A beta) deposition: A beta 42(43) precedes A beta 40 in Down syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901657-3

7 January 2021

Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43).

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901657-3

7 January 2021

The beta APP717 Alzheimer mutation increases the percentage of plasma amyloid-beta protein ending at A beta42(43).

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901657-3

7 January 2021

Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901657-3

7 January 2021

Amyloid-associated proteins α1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901657-3

7 January 2021

Amyloid beta protein (Abeta) deposition in chromosome 14-linked Alzheimer's disease: predominance of Abeta42(43).

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901657-3

7 January 2021

The apolipoprotein epsilon 4 allele in patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901657-3

7 January 2021

Plasma amyloid beta-peptide 1-42 and incipient Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901657-3

7 January 2021

Apolipoprotein E genotype and deposits of Abeta40 and Abeta42 in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901657-3

7 January 2021

Increased plasma amyloid beta protein 1-42 levels in Down syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901657-3

7 January 2021

Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901657-3

7 January 2021

Apolipoprotein E epsilon 2 allele promotes longevity and protects patients with Down's syndrome from dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901657-3

7 January 2021

Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901657-3

7 January 2021

Onset of dementia is associated with apolipoprotein E epsilon4 in Down's syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901657-3

7 January 2021

Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901657-3

7 January 2021

Plasma levels of amyloid beta proteins Abeta1-40 and Abeta1-42(43) are elevated in Down's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901657-3

7 January 2021

10.1016/S0304-3940(01)01657-3

Identifiers

DOI

1 reference

22 April 2018

1 reference

22 April 2018